Author:
Behets Geert J.,Spasovski Goce,Sterling Lulu R.,Goodman William G.,Spiegel David M.,De Broe Marc E.,D'Haese Patrick C.
Reference28 articles.
1. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options;Cunningham;Clin J Am Soc Nephrol,2011
2. KDIGO Clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease—mineral and bone disorder (CKD-MBD);Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group;Kidney Int,2009
3. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease;Quarles;Exp Cell Res,2012
4. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease;Moe;Clin J Am Soc Nephrol,2010
5. The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism;Goodman;J Am Soc Nephrol,2002
Cited by
152 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献